101140 — InBioGen Co Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for InBioGen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS/A	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23,152	9,290	6,089	5,716	902
Net Total Accounts Receivable
Net Total Receivables	6,575	5,662	4,271	3,429	4,300
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31,902	16,733	11,332	9,280	5,321
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,361	3,691	2,595	1,186	0
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	274,475	144,284	145,704	162,730	159,993
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	77,775	36,362	2,114	2,117	1,862
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	96,452	37,400	2,621	2,894	2,350
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	178,023	106,884	143,083	159,837	157,644
Total Liabilities & Shareholders' Equity	274,475	144,284	145,704	162,730	159,993
Total Common Shares Outstanding
Total Preferred Shares Outstanding